ZA946125B - Novel macrolides and the use thereof - Google Patents

Novel macrolides and the use thereof

Info

Publication number
ZA946125B
ZA946125B ZA946125A ZA946125A ZA946125B ZA 946125 B ZA946125 B ZA 946125B ZA 946125 A ZA946125 A ZA 946125A ZA 946125 A ZA946125 A ZA 946125A ZA 946125 B ZA946125 B ZA 946125B
Authority
ZA
South Africa
Prior art keywords
novel macrolides
macrolides
novel
Prior art date
Application number
ZA946125A
Other languages
English (en)
Inventor
Axel Zeeck
Kai Uwe Bindseil
Claudia Boddien
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of ZA946125B publication Critical patent/ZA946125B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/58—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA946125A 1993-08-16 1994-08-15 Novel macrolides and the use thereof ZA946125B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH243593 1993-08-16

Publications (1)

Publication Number Publication Date
ZA946125B true ZA946125B (en) 1995-02-16

Family

ID=4233741

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA946125A ZA946125B (en) 1993-08-16 1994-08-15 Novel macrolides and the use thereof

Country Status (13)

Country Link
US (1) US5610178A (fi)
EP (1) EP0639644A1 (fi)
JP (1) JPH07157433A (fi)
KR (1) KR950005306A (fi)
CN (1) CN1106401A (fi)
AU (1) AU683067B2 (fi)
CA (1) CA2130044A1 (fi)
FI (1) FI943734A (fi)
HU (1) HUT70524A (fi)
IL (1) IL110659A0 (fi)
NZ (1) NZ264219A (fi)
SG (1) SG49853A1 (fi)
ZA (1) ZA946125B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2152765A1 (en) * 1994-06-30 1995-12-31 Jeroen Elisabeth-Joseph Knops Methods for treating a physiological disorder associated with beta amyloid peptide
US6605599B1 (en) * 1997-07-08 2003-08-12 Bristol-Myers Squibb Company Epothilone derivatives
AU781133B2 (en) * 1999-02-26 2005-05-05 Nicox S.A. Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
AU4682700A (en) * 1999-04-30 2000-11-17 Research Corporation Technologies, Inc. Bone targeting agents for osteoporosis
DE10040052A1 (de) * 2000-08-11 2002-03-07 Univ Eberhard Karls Verwendung von Protonenpumpen-Hemmern zur Behandlung von Entzündungen, insbesondere von Erkrankungen des Bewegungsapparates
SI1483251T1 (sl) 2002-03-12 2010-03-31 Bristol Myers Squibb Co C cian epotilonski derivati
BR0313039A (pt) * 2002-07-31 2005-08-09 Mercian Corp Composto, medicamento, composição farmacêutica, método para prevenir ou tratar uma doença contra a qual um controle da expressão do gene é eficaz, método para prevenir ou tratar uma doença contra a qual a supressão da produção de vegf é eficaz, método para prevenir ou tratar uma doença contra a qual uma inibição da angiogênese é eficaz, uso do composto, método para produzir um composto 9-desoxi 1107, linhagem streptomyces sp. a-1543 (ferm bp-8442), método de produzir um composto 6- desoxi, e linhagem a-1544 (ferm bp-8446) ou linhagem a-1545 (ferm bp-8447)
JP4634144B2 (ja) * 2002-08-01 2011-02-16 ニコックス エスエー ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
US8463852B2 (en) * 2006-10-06 2013-06-11 Oracle International Corporation Groupware portlets for integrating a portal with groupware systems
WO2009098320A2 (en) * 2008-02-08 2009-08-13 Basilea Pharmaceutica Ag Macrolides and uses of macrolides
US20120225889A1 (en) * 2009-11-17 2012-09-06 Piramal Life Sciences Limited Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders
EP4263516A1 (en) * 2020-12-16 2023-10-25 The Regents of The University of Michigan Inhibitors of nef downmodulation
WO2024073129A1 (en) * 2022-09-30 2024-04-04 Sherman David H Novel plecomacrolide derivatives for mhc-i nef downmodulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8903529D0 (sv) * 1989-10-24 1989-10-24 M Hersloef Medical use
JPH0559046A (ja) * 1991-06-26 1993-03-09 Ajinomoto Co Inc 免疫調節剤
US5273979A (en) * 1991-08-01 1993-12-28 Merck & Co., Inc. C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agent

Also Published As

Publication number Publication date
US5610178A (en) 1997-03-11
NZ264219A (en) 1995-03-28
SG49853A1 (en) 2001-07-24
JPH07157433A (ja) 1995-06-20
AU683067B2 (en) 1997-10-30
FI943734A0 (fi) 1994-08-12
CN1106401A (zh) 1995-08-09
FI943734A (fi) 1995-02-17
HU9402361D0 (en) 1994-10-28
EP0639644A1 (de) 1995-02-22
IL110659A0 (en) 1994-11-11
AU6899994A (en) 1995-02-23
HUT70524A (en) 1995-10-30
CA2130044A1 (en) 1995-02-17
KR950005306A (ko) 1995-03-20

Similar Documents

Publication Publication Date Title
HU9600932D0 (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
GB9318439D0 (en) Probiotics
ZA946125B (en) Novel macrolides and the use thereof
GB2281830B (en) I/q-modulator and i/q-demodulator
EP0744125A3 (en) Iodine complex and its application
IL105873A0 (en) Pyrimidinyl-and triazinyl-salicyl-and-picolyl-amides and the use and preparation thereof
GB9501907D0 (en) Allatostatins and their use
ZA942246B (en) Novel imidazolo-quinoxalinones their preparation and use
GB9306456D0 (en) Composition and use
ZA932458B (en) Naphtoquinones and their use.
GB9415268D0 (en) Ropes and the use thereof
GB9408859D0 (en) Composition and use
GB2451221B (en) Azidoalkylformals, their prepararion and use
GB9304269D0 (en) Aerogel-containing galzing unit and manufacture thereof
ZA942736B (en) Compounds and use
GB9311223D0 (en) Compounds and use
GB9324258D0 (en) Biosensor and its use
ZA947921B (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
HU9302917D0 (en) Preparatives with roborant effect
GB9306322D0 (en) Ellbow ease
GB9321400D0 (en) Novel dicyanomethanides and devices employing them
GB9323081D0 (en) The icebraker
GB9311161D0 (en) The gripit
GB9300857D0 (en) The bugscoop
GB9313440D0 (en) The shoppa